Literature DB >> 23945963

Microalbuminuria, macroalbuminuria and uncontrolled blood pressure among diagnosed hypertensive patients: the aspect of racial disparity in the NHANES study.

Xuefeng Liu1, Kesheng Wang, Liang Wang, Dennis Tsilimingras.   

Abstract

Accumulating evidence reveals that albuminuria may exacerbate uncontrolled blood pressure (BP) in hypertensive patients. However, racial differences in the associations of albuminuria with uncontrolled BP among diagnosed hypertensives have not been evaluated. A total of 6147 diagnosed hypertensive subjects aged ≥ 18 years were collected from the National Health and Nutrition Examination Survey 1999-2008 with stratified multistage sampling designs. Odds ratios (ORs), relative ORs and 95% confidence intervals (CIs) in uncontrolled BP, and the different effects of microalbuminuria and macroalbuminuria on continuous BP were estimated using weighted logistic models and linear regression models. Hypertensive subjects with microalbuminuria and macroalbuminuria were more likely to have uncontrolled BP and higher average systolic BP (SBP) in all individual racial groups. Microalbuminuria was associated with isolated uncontrolled SBP in non-Hispanic blacks and whites, and macroalbuminuria was associated with isolated uncontrolled SBP and diastolic BP (DBP) and high average DBP only in non-Hispanic blacks. Compared with non-Hispanic whites, non-Hispanic blacks and Mexicans had lower associations of microalbuminuria with uncontrolled BP (relative OR = 0.68, 95% CI = 0.48-0.97 for blacks vs whites; relative OR = 0.62, 95% CI = 0.42-0.93 for Mexicans vs. whites) and isolated uncontrolled SBP (relative OR = 0.62, 95% CI = 0.43-0.90 for blacks vs. whites; relative OR = 0.45, 95% CI = 0.29-0.71 for Mexicans vs. whites). The association of microalbuminuria with uncontrolled BP was lower in non-Hispanic blacks and Mexicans than in non-Hispanic whites. Health providers need to improve care for mildly elevated albumin excretion rates in non-Hispanic white hypertensive patients while maintaining the quality of care in non-Hispanic blacks and Mexicans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23945963     DOI: 10.1038/hr.2013.87

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife.

Authors:  Holly Kramer; Laura Colangelo; Cora E Lewis; David R Jacobs; Mark Pletcher; Kirstin Bibbins-Domingo; Alex Chang; David Siscovick; Michael Shlipak; Carmen A Peralta; Nisha Bansal; Paul Muntner; Kiang Liu
Journal:  Am J Hypertens       Date:  2017-05-01       Impact factor: 2.689

Review 2.  Personalized Management of Cardiovascular Disorders.

Authors:  Kewal K Jain
Journal:  Med Princ Pract       Date:  2017-09-11       Impact factor: 1.927

3.  Prevalence and control of hypertension and albuminuria in South Korea: focus on obesity and abdominal obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Su-Jung Yoon; Do-Hoon Kim; Ga-Eun Nam; Yeo-Joon Yoon; Kyung-Do Han; Dong-Wook Jung; Sang-Woon Park; Young-Eun Kim; Sung-Ho Lee; Sang-Su Lee; Yang-Hyun Kim
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  Relationship Between Dyslipidemia and Albuminuria in Hypertensive Adults: A Nationwide Population-Based Study.

Authors:  Sung-Ho Lee; Do Hoon Kim; Yang-Hyun Kim; Yong Kyun Roh; Sang Yhun Ju; Hyo-Yun Nam; Ga-Eun Nam; Jun-Seok Choi; Jong-Eun Lee; Jung-Eun Sang; Kyungdo Han; Yong-Gyu Park
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Association of systolic blood pressure and pulse pressure with microalbuminuria in treatment-naïve hypertensive patients.

Authors:  Nianjin Xie; Xida Li; Qi Zhong; Dan Zhou; Anping Cai; Ying Zhang; Yingling Zhou; Yingqing Feng
Journal:  Arch Med Sci       Date:  2018-08-23       Impact factor: 3.318

6.  Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).

Authors:  Akinkunle Oye-Somefun; Jennifer L Kuk; Chris I Ardern
Journal:  BMC Cardiovasc Disord       Date:  2021-07-26       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.